Drug Patent Expirations for Mar 31, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

LONSURF (tipiracil hydrochloride; trifluridine)
Taiho Oncology
Patent number: 5,744,475
Expiration Date: Mar 28, 2016

EMTRIVA (emtricitabine)
Gilead
Patent number: 5,814,639
Expiration Date: Mar 29, 2016

COMPLERA (emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate)
Gilead Sciences Inc
Patent number: 5,814,639
Expiration Date: Mar 29, 2016

TRUVADA (emtricitabine; tenofovir disoproxil fumarate)
Gilead
Patent number: 5,814,639
Expiration Date: Mar 29, 2016

STRIBILD (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate)
Gilead Sciences Inc
Patent number: 5,814,639
Expiration Date: Mar 29, 2016

ATRIPLA (efavirenz; emtricitabine; tenofovir disoproxil fumarate)
Gilead
Patent number: 5,814,639
Expiration Date: Mar 29, 2016

ENTEREG (alvimopan)
Cubist Pharms
Patent number: 5,250,542
Expiration Date: Mar 29, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: